World Kidney Day Steering Committee 2013. Acute Kidney Injury: Global Health Alert


Дәйексөз келтіру

Толық мәтін

Ашық рұқсат Ашық рұқсат
Рұқсат жабық Рұқсат берілді
Рұқсат жабық Рұқсат ақылы немесе тек жазылушылар үшін

Аннотация

Острое почечное повреждение (ОПП) становится все более распространенной патологией как в развивающихся, так и в развитых странах, ассоциировано с существенной заболеваемостью и смертностью пациентов. в значительной мере развитие ОПП может быть предупреждено вмешательствами на различных уровнях медицинского обслуживания - индивидуальном, поликлиническом и госпитальном. Эффективные меры должны включать в первую очередь усилия, направленные на осведомленность общества о разрушительном влиянии ОПП на состояние здоровья населения, и выработку рекомендаций по предупреждению, раннему распознаванию и лечению ОПП. Усилия должны быть сконцентрированы на минимизации факторов, вызывающих ОПП, распространении информации о важности регулярного определения уровня сывороточного креатинина у пациентов групп риска и мониторирования объема мочи у пациентов, находящихся в критическом состоянии, с тем чтобы осуществлять возможно более раннюю диагностику; роль альтернативных биомаркеров ОПП до настоящего времени не определена. Необходимо создание протоколов для систематического лечения состояний, ведущих к развитию преренального ОПП, и специфических инфекций. Более точные данные о заболеваемости и клинической роли ОПП позволят повысить общественную значимость этой патологии, осведомленность правительственных и общественных организаций, представителей здравоохранения и практикующих врачей, что в конченом итоге позволит предотвращать развитие ОПП. Именно предотвращение является ключевым моментом, необходимым, чтобы избежать тяжелых последствий - заболеваемости и смертности, ассоциированных с ОПП.

Толық мәтін

Рұқсат жабық

Авторлар туралы

Philip Li

Emmanuel Burdmann

Ravindra Mehta

Әдебиет тізімі

  1. KDIGO. Clinical Practice Guideline for Acute Kidney Injury. Kidney Int 2012; (Suppl.) 2:1-138.
  2. Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007; 18:1292-1298.
  3. Hsu CY, McCulloch CE, Fan D, et al. Community-based incidence of acute renal failure. Kidney Int 2007; 72:208-212.
  4. Fang Y, Ding X, Zhong Y, et al. Acute kidney injury in a Chinese hospitalized population. Blood Purif. 2010; 30:120-126.
  5. Lafrance JP, Miller DR. Acute kidney injury associates with increased long-term mortality. J Am Soc Nephrol. 2010; 21: 345-352.
  6. Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005; 294: 813-818.
  7. Murugan R, Kellum JA. Acute kidney injury: what's the prognosis? Nat Rev Nephrol. 2011; 7: 209-217.
  8. Coca SG, Singanamala S, Parikh CR. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int 2012; 81: 442-448.
  9. Santos WJ, Zanetta DM, Pires AC, et al. Patients with ischaemic, mixed and nephrotoxic acute tubular necrosis in the intensive care unit - a homogeneous population? Crit Care 2006; 10: R68.
  10. Lombardi R, Yu L, Younes-Ibrahim M, et al. Epidemiology of acute kidney injury in Latin America. Semin Nephrol. 2008; 28: 320-329.
  11. Naicker S, Aboud O, Gharbi MB. Epidemiology of acute kidney injury in Africa. Semin Nephrol. 2008; 28: 348-353.
  12. Jha V, Rathi M. Natural medicines causing acute kidney injury. Semin Nephrol. 2008; 28 (4):416-428.
  13. Abdulkader RC, Barbaro KC, Barros EJ, et al. Nephrotoxicity of insect and spider venoms in Latin America. Semin Nephrol. 2008; 28: 373-382.
  14. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11:R31.
  15. Cruz DN, Ricci Z, Ronco C. Clinical review: RIFLE and AKIN - time for reappraisal. Crit Care 2009;13:211.
  16. Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012;380:756-766.
  17. Goldstein SL. Acute kidney injury in children and its potential consequences in adulthood. Blood Purif 2012;33:131-137.
  18. Chronopoulos A, Cruz DN, Ronco C. Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol. 2010; 6: 141-149.
  19. Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 2008;3:844-61.
  20. Cerda J, Lameire N, Eggers P, et al. Epidemiology of acute kidney injury. Clin J Am Soc Nephrol 2008;3:881-886.
  21. Perazella, MA. Drug use and nephrotoxicity in the intensive care unit. Kidney Int 2012;81:1172-1178.
  22. Zarjou A, Agarwal A. Sepsis and acute kidney injury. J Am Soc Nephrol. 2011; 22: 999-1006.
  23. Solomon R, Dauerman HL. Contrast-induced acute kidney injury. Circulation 2010;122: 2451-2455.
  24. Singbartl K, Kellum JA. AKIin the ICU: definition, epidemiology, risk stratification, and outcomes. Kidney Int. 2012; 81:819-825.
  25. NIH, NIDDKD, Bethesda, MD. USRDS 2010 Annual Data Report: Atlas of CKD and ESRD in the United States. 2010.
  26. Gonçalves GM, Zamboni DS, Câmara NO. The role of innate immunity in septic acute kidney injuries. Shock 2010; 34 Suppl 1: 22-26.
  27. Macedo E, Malhotra R, Bouchard J, et al. Oliguria is an early predictor of higher mortality in critically ill patients. Kidney Int 2011; 80:760-767.
  28. MacLeod A. NCEPOD report on acute kidney injury- must do better. Lancet 2009; 374: 1405-1406.
  29. Prescott AM, Lewington A, O'Donoghue D. Acute kidney injury: top ten tips. Clin Med. 2012; 12: 328-332.
  30. Basu RK, Chawla LS, Wheeler DS, et al. Renal angina: an emerging paradigm to identify children at risk for acute kidney injury. Pediatr Nephrol. 2012; 27: 1067-1078.
  31. Mammen C, Al Abbas A, Skippen P, et al. Long-term risk of CKD in children surviving episodes of acute kidney injury in the intensive care unit: a prospective cohort study. Am J Kidney Dis. 2012; 59: 523-530.
  32. Vieira JM Jr, Castro I, Curvello-Neto A, et al. Effect of acute kidney injury on weaningfrom mechanical ventilation in critically ill patients. Crit Care Med. 2007; 35: 184-191.
  33. Bouchard J, Soroko SB, Chertow GM, et al. Program to Improve Care in Acute Renal Disease (PICARD) Study Group. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76: 422-427.
  34. Fischer MJ, Brimhall BB, Parikh CR. Uncomplicated acute renal failure and post-hospital care: a not so uncomplicated illness. Am J Nephrol. 2008;28: 523-530.
  35. Thakar CV, Christianson A, Himmelfarb J, et al. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol. 2011;6: 2567-2572.
  36. Bydash JR, Ishani A. Acute kidney injury and chronic kidney disease: a work in progress. Clin J Am Soc Nephrol. 2011;6: 2555-2557.
  37. Li PK, Chow KM, Matsuo S, et al. Asian Chronic Kidney Disease (CKD) Best Practice Recommendations - Positional Statements for Early Detection of CKD from Asian Forum for CKD Initiatives (AFCKDI). Nephrology 2011 (Carlton); 16: 633-641.
  38. Fliser D, Laville M, Covic A, et al. A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy. Nephrol Dial Transplant 2012 Oct 19. [Epub ahead of print].
  39. Cho A, Lee JE, Yoon JY, et al. Effect of an electronic alert on risk of contrast-induced acute kidney injury in hospitalized patients undergoing computed tomography. Am J Kidney Dis 2012;60: 74-81.
  40. Cox ZL, Nelsen CL, Waitman LR, et al. Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin. Am J Health Syst Pharm 2011; 68: 624-632.
  41. Colpaert K, Hoste EA, Steurbaut K, et al. Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med 2012; 40: 1164-1170.
  42. Mehta RL. Biomarker explorations in acute kidney injury: the journey continues. Kidney Int. 2011; 80:332-334.
  43. Endre ZH, Walker RJ, Pickering JW, et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 2010; 77:1020-1030.
  44. Andrade L, de Francesco Daher E, Seguro AC. Leptospiral nephropathy. Semin Nephrol. 2008; 28: 383-394.
  45. Cerdá J, Bagga A, Kher V, Chakravarthi RM. The contrasting characteristics of acute kidney injury in developed and developing countries. Nat Clin Pract Nephrol. 2008; 4:138-153.
  46. Claure-Del Granado R, Macedo E, Chertow GM, et al. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol 2011; 6: 467-475.
  47. Ponce D, Berbel MN, Regina de Goes C, et al. High-volume peritoneal dialysis in acute kidney injury: indications and limitations. Clin J Am Soc Nephrol. 2012; 7: 887-894.
  48. Kilonzo KG, Ghosh S, Temu SA, et al. Outcome of acute peritoneal dialysis in northern Tanzania. Perit Dial Int. 2012; 32: 261-266.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>